HLS THERAPEUTICS INC (HLS.CA) Stock Earnings & Estimates
Canada - Toronto Stock Exchange - TSX:HLS - CA40390B1094 - Common Stock
4.86 CAD
-0.05 (-1.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 61.5M 2.50% | 63.074M 2.56% | 56.619M -10.23% | 55.522M -1.94% | 60.564M 9.08% | 63.529M 4.90% | 66.913M 5.33% | 71.649M 7.08% | 75.346M 5.16% | |
| EBITDA YoY % growth | 20.9M -13.13% | 20.129M -3.69% | 13.523M -32.82% | 19.706M 45.72% | 22.532M 14.34% | 28.179M 25.06% | 34.542M 22.58% | 40.4M 16.96% | 45.955M 13.75% | |
| EBIT YoY % growth | -13.5M -117.74% | -11.81M 12.52% | -9.194M 22.15% | -4.949M 46.17% | -1.01M 79.59% | 3.939M 490.00% | 10.302M 161.54% | 16.16M 56.86% | 21.715M 34.38% | |
| Operating Margin | -21.95% | -18.72% | -16.24% | -8.91% | -1.67% | 6.20% | 15.40% | 22.55% | 28.82% | |
| EPS YoY % growth | -0.59 -43.90% | -0.85 -44.07% | -0.62 27.06% | -0.39 37.55% | -0.17 56.96% | -0.13 21.21% | 0.14 207.69% | 0.32 128.57% | 0.51 56.25% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 69.70% | -0.08 42.29% | -0.05 43.89% | -0.05 57.92% | -0.03 |
| Revenue Q2Q % growth | 15.15M -2.52% | 13.686M 8.42% | 15.706M 10.83% | 15.756M 16.62% | 17.473M 15.33% |
| EBITDA Q2Q % growth | 5.858M -73.46% | 4.798M 67.00% | 5.757M -42.63% | 5.909M -59.10% | 6.414M 9.49% |
| EBIT Q2Q % growth | -505K 21.58% | -1.111M 55.33% | -202K 75.03% | 100.00% | 909K 280.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.12 20.00% | -0.07 | -0.05 | -69.73% |
| Q2 2025 Q2Q % growth | -0.09 50.00% | -0.07 | -0.02 | -27.30% |
| Q1 2025 Q2Q % growth | -0.14 26.32% | -0.12 | -0.02 | -16.97% |
| Q4 2024 Q2Q % growth | -0.10 41.18% | -0.09 | -0.01 | -11.88% |
| Q3 2024 Q2Q % growth | -0.15 28.57% | -0.15 | 0.00 | -2.42% |
| Q2 2024 Q2Q % growth | -0.18 37.93% | -0.18 | 0.00 | 0.99% |
| Q1 2024 Q2Q % growth | -0.19 -5.56% | -0.19 | 0.00 | -1.69% |
| Q4 2023 Q2Q % growth | -0.17 15.00% | -0.10 | -0.07 | -77.18% |
| Q3 2023 Q2Q % growth | -0.21 -50.00% | -0.10 | -0.11 | -118.86% |
| Q2 2023 Q2Q % growth | -0.29 -107.14% | -0.13 | -0.16 | -129.70% |
| Q1 2023 Q2Q % growth | -0.18 -63.64% | -0.12 | -0.06 | -54.97% |
| Q4 2022 Q2Q % growth | -0.20 -53.85% | -0.07 | -0.13 | -170.04% |
| Q3 2022 Q2Q % growth | -0.14 -133.33% | -0.13 | -0.01 | -3.96% |
| Q2 2022 Q2Q % growth | -0.14 -100.00% | -0.08 | -0.06 | -84.82% |
| Q1 2022 Q2Q % growth | -0.11 26.67% | -0.10 | -0.01 | -6.25% |
| Q4 2021 Q2Q % growth | -0.13 48.00% | -0.10 | -0.03 | -28.71% |
| Q3 2021 Q2Q % growth | -0.06 -20.00% | -0.11 | 0.05 | 45.99% |
| Q2 2021 Q2Q % growth | -0.07 65.00% | -0.15 | 0.08 | 53.80% |
| Q1 2021 Q2Q % growth | -0.15 | -0.15 | 0.00 | 3.14% |
| Q4 2020 Q2Q % growth | -0.25 37.50% | -0.07 | -0.18 | -280.81% |
| Q3 2020 Q2Q % growth | -0.05 16.67% | -0.15 | 0.10 | 65.86% |
| Q2 2020 Q2Q % growth | -0.20 -233.33% | -0.14 | -0.06 | -46.68% |
| Q1 2020 Q2Q % growth | 0.00 100.00% | -0.20 | 0.20 | 100.00% |
| Q4 2019 Q2Q % growth | -0.40 | -0.08 | -0.32 | -395.05% |
| Q3 2019 Q2Q % growth | -0.06 | -0.06 | 0.00 | -8.01% |
| Q2 2019 Q2Q % growth | -0.06 | -0.05 | -0.01 | -32.01% |
| Q1 2019 Q2Q % growth | -0.14 | -0.10 | -0.04 | -45.91% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 13.511M -4.08% | 14.468M | -957K | -6.61% |
| Q2 2025 Q2Q % growth | 14.171M -2.40% | 14.645M | -474K | -3.24% |
| Q1 2025 Q2Q % growth | 12.623M 1.20% | 12.645M | -22K | -0.17% |
| Q4 2024 Q2Q % growth | 15.542M -2.02% | 15.857M | -315K | -1.99% |
| Q3 2024 Q2Q % growth | 14.085M -12.17% | 14.948M | -863K | -5.77% |
| Q2 2024 Q2Q % growth | 14.519M -11.56% | 14.504M | 15K | 0.10% |
| Q1 2024 Q2Q % growth | 12.473M -15.48% | 14.706M | -2.233M | -15.18% |
| Q4 2023 Q2Q % growth | 15.863M 1.17% | 16.615M | -752K | -4.53% |
| Q3 2023 Q2Q % growth | 16.037M 2.15% | 16.438M | -401K | -2.44% |
| Q2 2023 Q2Q % growth | 16.417M 5.71% | 16.009M | 408K | 2.55% |
| Q1 2023 Q2Q % growth | 14.757M 1.35% | 15.756M | -999K | -6.34% |
| Q4 2022 Q2Q % growth | 15.68M -0.06% | 17.173M | -1.493M | -8.69% |
| Q3 2022 Q2Q % growth | 15.7M 4.25% | 16.749M | -1.049M | -6.26% |
| Q2 2022 Q2Q % growth | 15.53M 3.88% | 16.747M | -1.217M | -7.27% |
| Q1 2022 Q2Q % growth | 14.56M 1.75% | 15.739M | -1.179M | -7.49% |
| Q4 2021 Q2Q % growth | 15.69M -4.85% | 16.896M | -1.206M | -7.14% |
| Q3 2021 Q2Q % growth | 15.06M 14.70% | 16.046M | -986K | -6.14% |
| Q2 2021 Q2Q % growth | 14.95M 18.56% | 14.948M | 2K | 0.01% |
| Q1 2021 Q2Q % growth | 14.31M 3.02% | 15.016M | -706K | -4.70% |
| Q4 2020 Q2Q % growth | 16.49M 18.29% | 16.367M | 123K | 0.75% |
| Q3 2020 Q2Q % growth | 13.13M -2.23% | 13.374M | -244K | -1.82% |
| Q2 2020 Q2Q % growth | 12.61M -7.48% | 13.821M | -1.211M | -8.76% |
| Q1 2020 Q2Q % growth | 13.89M 5.47% | 12.995M | 895K | 6.89% |
| Q4 2019 Q2Q % growth | 13.94M | 14.175M | -235K | -1.66% |
| Q3 2019 Q2Q % growth | 13.43M | 14.948M | -1.518M | -10.16% |
| Q2 2019 Q2Q % growth | 13.63M | 15.245M | -1.615M | -10.59% |
| Q1 2019 Q2Q % growth | 13.17M | 13.84M | -670K | -4.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 40% | 40% | -19.79% | -16.16% |
| Revenue | -6.39% | -6.39% | -4.07% | -4.07% |